+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2020

  • ID: 5023494
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
1 of 2
The research report Global Dry Age-Related Macular Degeneration Market and Competitive Landscape - 2020, provides comprehensive insights into the Dry Age-Related Macular Degeneration pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Dry Age-Related Macular Degeneration market size and drug sales. It also provides insights into Dry Age-Related Macular Degeneration epidemiology and late stage pipeline.

This research covers the following: Dry Age-Related Macular Degeneration treatment options, Dry Age-Related Macular Degeneration late stage clinical trials pipeline, Dry Age-Related Macular Degeneration prevalence by countries, Dry Age-Related Macular Degeneration market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Dry Age-Related Macular Degeneration pipeline: Find out drugs in clinical trials for the treatment of Dry Age-Related Macular Degeneration by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Dry Age-Related Macular Degeneration epidemiology: Find out the number of patients diagnosed (prevalence) with Dry Age-Related Macular Degeneration by countries
  • Dry Age-Related Macular Degeneration drugs: Identify key drugs marketed and prescribed for Dry Age-Related Macular Degeneration in the US, including trade name, molecule name, and company
  • Dry Age-Related Macular Degeneration drugs sales: Find out the sales value for Dry Age-Related Macular Degeneration drugs by countries
  • Dry Age-Related Macular Degeneration market valuations: Find out the market size for Dry Age-Related Macular Degeneration drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Dry Age-Related Macular Degeneration drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Dry Age-Related Macular Degeneration drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Dry Age-Related Macular Degeneration market
  • Develop in-depth knowledge of competition and markets
  • Analyze Dry Age-Related Macular Degeneration drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Dry Age-Related Macular Degeneration market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies
Note: Product cover images may vary from those shown
2 of 2
1. Dry Age-Related Macular Degeneration Treatment Options

2. Dry Age-Related Macular Degeneration Pipeline Insights
2.1. Dry Age-Related Macular Degeneration Phase 3 Clinical Trials
2.2. Dry Age-Related Macular Degeneration Phase 2 Clinical Trials
2.3. Dry Age-Related Macular Degeneration Phase 1 Clinical Trials

3. Dry Age-Related Macular Degeneration Epidemiology Analysis by Countries

4. US Dry Age-Related Macular Degeneration Market Insights
4.1. Marketed Drugs for Dry Age-Related Macular Degeneration in US
4.2. US Dry Age-Related Macular Degeneration Market Size & Forecast
4.3. US Dry Age-Related Macular Degeneration Drugs Sales & Forecast
4.4. US Dry Age-Related Macular Degeneration Market Share Analysis

5. Germany Dry Age-Related Macular Degeneration Market Insights
5.1. Marketed Drugs for Dry Age-Related Macular Degeneration in Germany
5.2. Germany Dry Age-Related Macular Degeneration Market Size & Forecast
5.3. Germany Dry Age-Related Macular Degeneration Drugs Sales Forecast
5.4. Germany Dry Age-Related Macular Degeneration Market Share Analysis

6. France Dry Age-Related Macular Degeneration Market Insights
6.1. Marketed Drugs for Dry Age-Related Macular Degeneration in France
6.2. France Dry Age-Related Macular Degeneration Market Size & Forecast
6.3. France Dry Age-Related Macular Degeneration Product Sales Forecast
6.4. France Dry Age-Related Macular Degeneration Market Share Analysis

7. Italy Dry Age-Related Macular Degeneration Market Insights
7.1. Marketed Drugs for Dry Age-Related Macular Degeneration in Italy
7.2. Italy Dry Age-Related Macular Degeneration Market Size & Forecast
7.3. Italy Dry Age-Related Macular Degeneration Product Sales Forecast
7.4. Italy Dry Age-Related Macular Degeneration Market Share Analysis

8. Spain Dry Age-Related Macular Degeneration Market Insights
8.1. Marketed Drugs for Dry Age-Related Macular Degeneration in Spain
8.2. Spain Dry Age-Related Macular Degeneration Market Size & Forecast
8.3. Spain Dry Age-Related Macular Degeneration Product Sales Forecast
8.4. Spain Dry Age-Related Macular Degeneration Market Share Analysis

9. UK Dry Age-Related Macular Degeneration Market Insights
9.1. Marketed Drugs for Dry Age-Related Macular Degeneration in UK
9.2. UK Dry Age-Related Macular Degeneration Market Size & Forecast
9.3. UK Dry Age-Related Macular Degeneration Product Sales Forecast
9.4. UK Dry Age-Related Macular Degeneration Market Share Analysis

10. Europe Dry Age-Related Macular Degeneration Market Insights
10.1. Europe Dry Age-Related Macular Degeneration Market Size & Forecast
10.2. Europe Dry Age-Related Macular Degeneration Product Sales Forecast
10.3. Europe Dry Age-Related Macular Degeneration Market Share Analysis

11. Japan Dry Age-Related Macular Degeneration Market Insights
11.1. Marketed Drugs for Dry Age-Related Macular Degeneration in Japan
11.2. Japan Dry Age-Related Macular Degeneration Market Size & Forecast
11.3. Japan Dry Age-Related Macular Degeneration Product Sales Forecast
11.4. Japan Dry Age-Related Macular Degeneration Market Share Analysis

12. Global Dry Age-Related Macular Degeneration Market Insights
12.1. Global Dry Age-Related Macular Degeneration Market Size & Forecast
12.2. Global Dry Age-Related Macular Degeneration Product Sales Forecast
12.3. Global Dry Age-Related Macular Degeneration Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Dry Age-Related Macular Degeneration Phase 3 Clinical Trials, Global, 2020
Table 2: Dry Age-Related Macular Degeneration Phase 2 Clinical Trials, Global, 2020
Table 3: Dry Age-Related Macular Degeneration Phase 1 Clinical Trials, Global, 2020
Table 4: Dry Age-Related Macular Degeneration Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Dry Age-Related Macular Degeneration in US, 2019
Table 6: US Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 8: US Dry Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Dry Age-Related Macular Degeneration in Germany, 2019
Table 10: Germany Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 12: Germany Dry Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Dry Age-Related Macular Degeneration in France, 2019
Table 14: France Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 16: France Dry Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Dry Age-Related Macular Degeneration in Italy, 2019
Table 18: Italy Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 20: Italy Dry Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Dry Age-Related Macular Degeneration in Spain, 2019
Table 22: Spain Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 24: Spain Dry Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Dry Age-Related Macular Degeneration in UK, 2019
Table 26: UK Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 28: UK Dry Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 29: Europe Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Dry Age-Related Macular Degeneration in Japan, 2019
Table 32: Japan Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 34: Japan Dry Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 35: Global Dry Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Dry Age-Related Macular Degeneration Pipeline by Phase (%), Global, 2020
Figure 2: Dry Age-Related Macular Degeneration Prevalence by Countries, 2016 - 2024
Figure 3: US Dry Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 4: US Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 5: US Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 6: US Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 7: Germany Dry Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 8: Germany Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 9: Germany Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 10: Germany Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 11: France Dry Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 12: France Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 13: France Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 14: France Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 15: Italy Dry Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 16: Italy Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 17: Italy Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 18: Italy Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 19: Spain Dry Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 20: Spain Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 21: Spain Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 22: Spain Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 23: UK Dry Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 24: UK Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 25: UK Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 26: UK Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 27: Europe Dry Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 28: Europe Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 29: Europe Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 30: Europe Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 31: Japan Dry Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 32: Japan Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 33: Japan Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 34: Japan Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 35: Global Dry Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 36: Global Dry Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 37: Global Dry Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 38: Global Dry Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll